Skip to main content

Gupta Rishi

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Gupta Rishi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ELVN Enliven Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 20, 2024 (view filing)May 164 daysGupta RishiDirector, 10% OwnerSSale−1.03M$22.14−$22.9M−11.9%7.66M after2 lots

TSBX Turnstone Biologics Corp.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 24, 2023 (view filing)Jul 204 daysGupta RishiDirector, 10% OwnerPPurchase+416.7K$12.00+$5.00M+15.5%3.10M after

VRNA Verona Pharma plc

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 27, 2022 (view filing)Dec 22-235 daysGupta RishiDirectorSSale−6.14M$22.15−$136.0M−15.3%34.1M after5 lots
May 15, 2023 (view filing)May 11-154 daysGupta RishiDirectorSSale−482.9K$20.58−$9.94M−11.3%3.78M after4 lots